Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2 $ 129,725 $ (72,258) $ 57,469
Balance (in Shares) at Dec. 31, 2020 23,264,637      
Exercise of stock options [1] 23 23
Exercise of stock options (in Shares) 12,646      
Exercise of warrant [1]  
Exercise of warrant (in Shares) 362,383      
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs** [1] 4,334 4,334
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs** (in Shares) 601,674      
Stock-based compensation expenses   530   530
Net loss (8,402) (8,402)
Balance at Mar. 31, 2021 $ 2 134,612 (80,660) 53,954
Balance (in Shares) at Mar. 31, 2021 24,241,340      
Balance at Dec. 31, 2021 $ 2 156,017 (108,484) 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs** [2] [1] 37 37
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs** (in Shares) [2] 27,171      
Stock-based compensation expenses 615 615
Net loss (8,169) (8,169)
Balance at Mar. 31, 2022 $ 2 $ 156,669 $ (116,653) $ 40,018
Balance (in Shares) at Mar. 31, 2022 29,774,709      
[1] Less than $1.
[2] See Note 5A.